JPH0459285B2 - - Google Patents
Info
- Publication number
- JPH0459285B2 JPH0459285B2 JP62024391A JP2439187A JPH0459285B2 JP H0459285 B2 JPH0459285 B2 JP H0459285B2 JP 62024391 A JP62024391 A JP 62024391A JP 2439187 A JP2439187 A JP 2439187A JP H0459285 B2 JPH0459285 B2 JP H0459285B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- formula
- fatty acid
- cholesterol
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 claims description 18
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 17
- -1 cholesterol fatty acid ester Chemical class 0.000 claims description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 11
- 239000000194 fatty acid Substances 0.000 claims description 11
- 229930195729 fatty acid Natural products 0.000 claims description 11
- 235000012000 cholesterol Nutrition 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 150000002430 hydrocarbons Chemical group 0.000 claims description 7
- 229930195734 saturated hydrocarbon Natural products 0.000 claims description 7
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 150000003904 phospholipids Chemical class 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 229930183167 cerebroside Natural products 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 3
- 150000001784 cerebrosides Chemical class 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 31
- 239000000203 mixture Substances 0.000 description 15
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 206010013786 Dry skin Diseases 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 2
- 210000000736 corneocyte Anatomy 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- YZUMRMCHAJVDRT-UHFFFAOYSA-N 2-(hexadecoxymethyl)oxirane Chemical compound CCCCCCCCCCCCCCCCOCC1CO1 YZUMRMCHAJVDRT-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- YBSQGNFRWZKFMJ-UHFFFAOYSA-N Cerebroside B Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O YBSQGNFRWZKFMJ-UHFFFAOYSA-N 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000008271 cosmetic emulsion Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 150000002327 glycerophospholipids Chemical class 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 229940125697 hormonal agent Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- PUGFCQQOYJMKOO-UHFFFAOYSA-N n-(3-hexadecoxy-2-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOCC(O)CN(CCO)C(=O)CCCCCCCCCCCCCCC PUGFCQQOYJMKOO-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
Description
〔産業上の利用分野〕
本発明は皮膚外用剤、更に詳しくは、角層の水
分保持力を高め、肌あれを改善することのできる
皮膚外用剤に関する。
〔従来の技術〕
従来、肌にうるおいを与え、肌を柔軟にするに
は、角質層の水分が重要であることが知られてい
る。そして、当該水分の保持は、角質層に含まれ
ている水溶性成分、すなわち遊離アミノ酸、有機
酸、尿素又は無機イオンによるものであるとさ
れ、これらの物質は単独であるいは組合せて薬用
皮膚外用剤あるいは化粧料に配合して、肌あれの
改善又は予防の目的で使用されている。
また、これとは別に水と親和性が高い多くの保
湿性物質が開発され、同様の目的で使用されてい
る。
〔発明が解決しようとする問題点〕
しかしながら、これらの保湿性物質は、皮膚に
適用した場合、その作用は、皮膚角質上にあつて
水分を角質に供給するというもので、しかもその
効果は一時的であり、根本的に角質層の水分保持
能力を改善し、肌あれを本質的に予防あるいは治
癒させるというものではなかつた。
〔問題点を解決するための手段〕
斯かる実情において、本発明者らは上記問題点
を解決すべく角質細胞間脂質に注目して鋭意研究
を行つたところ、大量に入手の容易な下記一般式
()で表わされる新規アミド誘導体及び角質細
胞間に存在する脂質で組合せたものが角質層の水
分保持能力を根本的に改善する効果を奏するこ
と、そして上記混合物に界面活性剤を併用すると
その効果を更に増大できることを見出し、本発明
を完成した。
すなわち、本発明は次の成分(A)及び(B)
(A) 一般式()
(式中、R3は炭素数10〜26の直鎖若しくは
分岐鎖の飽和若しくは不飽和の炭化水素基、
R4は炭素数9〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す)
で表わされるアミド誘導体の一種又は二種以
上、
(B) コレステロール、コレステロール脂肪酸エス
テル、脂肪酸、トリグリセリド、セレブロシド
又はリン脂質の一種又は二種以上、
を含有することを特徴とする皮膚外用剤を提供す
るものである。
本発明で使用されるアミド誘導体()は新規
な化合物であるが、公知の方法〔例えば、ポリツ
シユ・ジヤーナル・オブ・ケミストリー(Pol.J.
Chem.)52,1059(1978);同52,1283(1978);特
開昭54−117421号、同54−144308号、同54−
147937号公報〕に準じて製造することができる。
すなわち、次に示される反応式に従つて、グリシ
ジルエーテルとエタノールアミンから得られる化
合物()を脂肪酸メチルエステルと反応させる
ことによつて製造することができる。
(式中、R3及びR4は前記と同じ)
このようにアミド誘導体()は、安価かつ入
手の容易な原料から簡便かつ大量に製造すること
ができる。
コレステロールとしては、次式()
で表わされるものが最も好ましいが、3位水酸基
が残存しているものであれば如何なる誘導体も使
用できる。
コレステロール脂肪酸エステルとしては、式
()
(式中、R5は1個以上の水酸基が置換するこ
とのある炭素数1〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す)
で表わされるものが最も好ましいが、3位エステ
ル基が残存しているものであれば如何なる誘導体
も使用できる。
脂肪酸としては一般式()
R6−COOH ()
(式中、R6は1個以上の水酸基が置換するこ
とのある炭素数1〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す)
で表わされるものが使用できるが、炭素数14〜18
の直鎖の飽和若しくは不飽和の脂肪酸が最適であ
る。
トリグリセリドとしては一般式()
(式中、R7,R8,R9は1個以上の水酸基が置
換することのある炭素数1〜25の直鎖若しくは分
岐鎖の飽和若しくは不飽和の炭化水素基を示す)
で表わされるものが使用できる。
セレブロシドは、セラミドに糖が付加した複合
脂質であり、一般式()
(式中、Xはグルコース、ラクトース等の糖を
示し、R1及びR2は1個以上の水酸基が置換する
ことのある炭素数10〜26の直鎖若しくは分岐鎖の
飽和若しくは不飽和の炭化水素基を示す)
で表わされる。
リン脂質には、大別するとグリセリン誘導体で
あるグリセロリン脂質とセラミド誘導体であるス
フインゴリン脂質があるが、本発明にはその何れ
に含まれるものも使用できる。
本発明の皮膚外用剤への(A)成分及び(B)成分の配
合比は、重量比で8:2〜2:8が好ましい。こ
れらを配合するには、両者を上記比率で混合して
一旦加熱溶解後冷却してペースト状あるいは固体
状としたものを他の成分に添加するのが好ましい
が、またそれぞれを別個に添加してもよい。
成分(A)と成分(B)の混合物の本発明皮膚外用剤へ
の配合量は、特に制限されないが、通常乳化型の
皮膚外用剤の場合には全組成の0.01〜60重量%
(以下単に%で示す)、特に0.1〜30%が好ましく、
またスクワラン等の液状炭化水素を基剤とする油
性の皮膚外用剤の場合には1〜90%、特に5〜50
%が好ましい。
本発明の効果を更に増大するために併用される
界面活性剤としては、非イオン界面活性剤、陰イ
オン界面活性剤、両性界面活性剤の何れをも使用
できるが、就中非イオン界面活性剤が好適であ
る。
非イオン界面活性剤としては、例えばポリオキ
シエチレンアルキルエーテル、ポリオキシエチレ
ンアルキルフエニルエーテル、ポリオキシエチレ
ン脂肪酸エステル、ソルビタン脂肪酸エステル、
ポリオキシエチレンソルビタン脂肪酸エステル、
脂肪酸モノグリセライド、グリセリルエーテル等
が挙げられる。その中でも、次の一般式()
(式中、R10は炭素数8〜24のアルキル基を示
す)
で表わされるグリセリルエーテル、就中R10が次
式()
(式中、pは4〜10の整数、qは5〜11の整数
を示し、p+q=11〜17でp=7、q=8を頂点
とする分布を有する)
で表わされるものが特に好ましい。
界面活性剤の配合量は、全組成の0.01〜20%、
特に0.1〜5%が好ましい。
本発明の皮膚外用剤は、その使用形態におい
て、薬用皮膚外用剤と化粧料に大別される。
薬用皮膚外用剤としては、例えば薬効成分を含
有する各種軟膏剤を挙げることができる。軟膏剤
としては、油性基剤をベースとするもの、油/
水、水/油型の乳化系基剤をベースとするものの
いずれであつてもよい。油性基剤としては、特に
制限はなく、例えば植物油、動物油、合成油、脂
肪酸、及び天然又は合成のグリセライド等が挙げ
られる。また薬効成分としては、特に制限はな
く、例えば鎮痛消炎剤、鎮痒剤、殺菌消毒剤、収
斂剤、皮膚軟化剤、ホルモン剤等を必要に応じて
適宜使用することができる。
また、化粧料として使用する場合は、必須成分
の他に化粧料成分として一般に使用されている油
分、保湿剤、紫外線吸収剤、アルコール類、キレ
ート類、PH調整剤、防腐剤、増粘剤、色素、香料
等を任意に組合せて配合することができる。
化粧料としては、種々の形態、例えば水/油、
油/水型乳化化粧料、クリーム、化粧乳液、化粧
水、油性化粧料、口紅、フアウンデーシヨン、皮
膚洗浄剤、ヘアートニツク、整髪剤、養毛剤、育
毛剤等の皮膚化粧料とすることができる。
〔作用〕
本発明皮膚外用剤における、成分(A)と成分(B)の
混合物の作用機構の詳細は完全には解明されてい
ないが、これが角質細胞間で水とともに脂質2重
層を構築して、角質層の水分保持機能を発揮する
ものと考えられる。
〔発明の効果〕
本発明皮膚外用剤は、このような作用を有する
成分(A)と成分(B)の混合物を含有するものであるた
め、肌あれに対して優れた改善及び予防効果を発
揮することができる。
〔実施例〕
次に参考例及び実施例を挙げて説明する。
参考例 1
N−(2−ヒドロキシ−3−ヘキサデシロキシ
プロピル)−N−2−ヒドロキシエチルヘキサ
デカナミド〔式()において、R3=C16H33、
R4=C15H31のもの〕(a)の合成:
撹拌装置、滴下漏斗、温度計、還流冷却器およ
び窒素導入管を備えた54ツ口フラスコにエタ
ノールアミン1637g(26.8モル)および、エタノ
ール327g(7.11モル)を入れ、窒素雰囲気下で
80℃に加熱撹拌しつつ、これにヘキサデシルグリ
シジルエーテル400g(1.34モル)を3時間かけ
て滴下した。滴下終了後、更に同条件下30分間加
熱撹拌したのち、蒸留装置をとりつけ、エタノー
ルおよび、未反応のエタノールアミンを減圧下に
留去(79〜81℃/20Torr)した。80℃/20Torr
で加熱撹拌しつつ、これに、ヘキサデカン酸メチ
ル362.3g(1.34モル)を3時間かけて滴下した。
滴下終了後、更に同条件下、1時間加熱撹拌する
ことにより、淡黄色の粗生成物801gを得た。こ
れをヘキサンから1回、エタノールから2回再結
晶することにより、無色粉末の目的化合物(
a)649g(収率81%)を得た。
実施例 1
成分(A)と成分(B)の混合物の調製:
化合物(a)を60重量%、コレステロール
〔式()〕を40重量%となるようにガラスネジ口
のサンプル瓶に計量する。サンプル瓶をヒーテイ
ング・ブロツク等を用いて150℃となるように加
熱する。加熱して(a)及びコレステロールが
完全に溶解したら、加熱を終了し、空気中で放冷
してペースト状態の混合物を得る。
実施例 2
ワセリンに実施例1で得た混合物を(a)が
15重量%、コレステロールが10重量%になるよう
に添加配合して調製した皮膚外用剤(本発明品
1)、ワセリンに上記混合物を(a)が15重量
%、コレステロールが10重量%になるように加
え、更にグリセリルエーテル〔式()中R10が
式()のもの〕4重量%を配合して調製した皮
膚外用剤(本発明品2)、並びにワセリン(対照)
を用い、下記方法により皮膚コンダクタンス及び
肌あれについて評価した。結果を第1表に示す。
(試験方法)
冬期に頬部に肌あれを起こしている20〜〜50才
の女性10名を被験者とし、左右の頬に異なるサン
プルを毎日1回2週間塗布する。2週間の塗布が
終了した翌日に次の項目につき試験を行なつた。
(1) 皮膚コンダクタンス
37℃の温水にて洗顔後、温度20℃、湿度40%の
部屋で20分間安静にした後、角質層の水分含有量
を皮膚コンダクタンスメーター(IBS社製)にて
測定した。コンダクタンス値は値が小さいほど皮
膚は肌あれし、5以下ではひどい肌あれである。
一方この値が20以上であれば肌あれはほとんど認
められない。
(2) 肌あれスコア
肌あれを肉眼で観測し、下記基準により判定し
た。スコアは平均値±標準偏差で示した。
[Industrial Field of Application] The present invention relates to a skin preparation for external use, and more particularly, to a skin preparation for external use that can improve the moisture retention capacity of the stratum corneum and improve rough skin. [Prior Art] It has been known that the moisture in the stratum corneum is important for moisturizing the skin and making it soft. The retention of moisture is said to be due to water-soluble components contained in the stratum corneum, such as free amino acids, organic acids, urea, or inorganic ions, and these substances may be used alone or in combination in medicated skin preparations. Alternatively, it is used in cosmetics to improve or prevent rough skin. In addition, many other moisturizing substances that have a high affinity for water have been developed and are used for similar purposes. [Problem to be solved by the invention] However, when these moisturizing substances are applied to the skin, their action is to supply moisture to the stratum corneum on the skin, and the effect is temporary. However, it did not fundamentally improve the water retention ability of the stratum corneum or essentially prevent or cure rough skin. [Means for Solving the Problems] Under these circumstances, the present inventors conducted intensive research focusing on interkeratinocyte lipids in order to solve the above problems, and found that the following general lipids, which are easily available in large quantities, The combination of the novel amide derivative represented by the formula () and the lipid present between corneocytes has the effect of fundamentally improving the water retention ability of the stratum corneum, and that the combination of the above mixture with a surfactant improves the water retention ability of the stratum corneum. They discovered that the effect could be further increased and completed the present invention. That is, the present invention comprises the following components (A) and (B) (A) General formula () (In the formula, R 3 is a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms,
( R4 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms); (B) cholesterol, cholesterol fatty acid ester, fatty acid, triglyceride; The present invention provides an external skin preparation characterized by containing one or more of , cerebroside, or phospholipid. Although the amide derivative () used in the present invention is a new compound, it can be obtained by a known method [for example, Polytechnic Journal of Chemistry (Pol.J.
Chem.) 52 , 1059 (1978); 52 , 1283 (1978); JP 54-117421, 54-144308, 54-
147937].
That is, it can be produced by reacting a compound () obtained from glycidyl ether and ethanolamine with a fatty acid methyl ester according to the reaction formula shown below. (In the formula, R 3 and R 4 are the same as above.) In this way, the amide derivative () can be easily produced in large quantities from inexpensive and easily available raw materials. For cholesterol, the following formula () The derivative represented by is most preferred, but any derivative can be used as long as the hydroxyl group at the 3-position remains. For cholesterol fatty acid ester, the formula () (In the formula, R 5 represents a straight chain or branched chain saturated or unsaturated hydrocarbon group having 1 to 25 carbon atoms which may be substituted with one or more hydroxyl groups). Any derivative can be used as long as the 3-position ester group remains. The fatty acid has the general formula () R 6 -COOH () (where R 6 is a linear or branched saturated or unsaturated hydrocarbon having 1 to 25 carbon atoms that may be substituted with one or more hydroxyl groups). (representing a group) can be used, but those having 14 to 18 carbon atoms can be used.
Straight chain saturated or unsaturated fatty acids are most suitable. General formula () for triglyceride (In the formula, R 7 , R 8 , and R 9 represent a straight chain or branched chain saturated or unsaturated hydrocarbon group having 1 to 25 carbon atoms that may be substituted with one or more hydroxyl groups.) Things can be used. Cerebroside is a complex lipid made by adding sugar to ceramide, and has the general formula () (In the formula , (represents a hydrogen group). Phospholipids can be broadly classified into glycerophospholipids, which are glycerin derivatives, and sphingophospholipids, which are ceramide derivatives. Phospholipids included in either of these can be used in the present invention. The blending ratio of component (A) and component (B) in the external skin preparation of the present invention is preferably 8:2 to 2:8 by weight. To blend these, it is preferable to mix both in the above ratio, heat and melt, then cool to form a paste or solid, which is then added to the other ingredients, but it is also preferable to add each separately. Good too. The amount of the mixture of component (A) and component (B) in the skin preparation of the present invention is not particularly limited, but in the case of an emulsion-type skin preparation, it is usually 0.01 to 60% by weight of the total composition.
(hereinafter simply expressed as %), particularly preferably 0.1 to 30%,
In the case of oil-based external skin preparations based on liquid hydrocarbons such as squalane, 1 to 90%, especially 5 to 50%
% is preferred. As the surfactant used in combination to further increase the effects of the present invention, any of nonionic surfactants, anionic surfactants, and amphoteric surfactants can be used, but especially nonionic surfactants is suitable. Examples of nonionic surfactants include polyoxyethylene alkyl ether, polyoxyethylene alkyl phenyl ether, polyoxyethylene fatty acid ester, sorbitan fatty acid ester,
polyoxyethylene sorbitan fatty acid ester,
Examples include fatty acid monoglyceride and glyceryl ether. Among them, the following general formula () (In the formula, R 10 represents an alkyl group having 8 to 24 carbon atoms) Glyceryl ether represented by the following formula () (In the formula, p is an integer of 4 to 10, q is an integer of 5 to 11, and has a distribution where p+q=11 to 17, with p=7 and q=8 as the vertices) . The amount of surfactant added is 0.01 to 20% of the total composition.
Particularly preferred is 0.1 to 5%. The skin external preparations of the present invention are broadly classified into medicated skin external preparations and cosmetics in terms of their usage forms. Examples of medicated skin external preparations include various ointments containing medicinal ingredients. Ointments include those based on oily bases, oil/
It may be based on water or water/oil type emulsion base. The oily base is not particularly limited and includes, for example, vegetable oils, animal oils, synthetic oils, fatty acids, natural or synthetic glycerides, and the like. There are no particular limitations on the medicinal ingredients, and for example, analgesic and antiinflammatory agents, antipruritic agents, sterilizing disinfectants, astringents, emollients, hormonal agents, and the like can be used as appropriate. When used as a cosmetic, in addition to the essential ingredients, oils, moisturizers, ultraviolet absorbers, alcohols, chelates, PH adjusters, preservatives, thickeners, Any combination of dyes, fragrances, etc. can be blended. Cosmetics can be used in various forms, such as water/oil,
It can be used as skin cosmetics such as oil/water type emulsified cosmetics, creams, cosmetic emulsions, lotions, oil-based cosmetics, lipsticks, foundations, skin cleansers, hair tonics, hair conditioners, hair tonics, hair growth agents, etc. . [Action] Although the details of the mechanism of action of the mixture of component (A) and component (B) in the topical skin preparation of the present invention have not been completely elucidated, it is believed that it builds a lipid bilayer together with water between corneocytes. It is thought that it exerts the moisture retention function of the stratum corneum. [Effects of the Invention] Since the skin external preparation of the present invention contains a mixture of component (A) and component (B) that have the above-mentioned effects, it exhibits excellent improvement and prevention effects on rough skin. can do. [Example] Next, reference examples and examples will be given and explained. Reference Example 1 N-(2-hydroxy-3-hexadecyloxypropyl)-N-2-hydroxyethylhexadecanamide [In formula (), R 3 = C 16 H 33 ,
R 4 = C 15 H 31 ] Synthesis of (a): 1637 g (26.8 mol) of ethanolamine and ethanol were placed in a 54-necked flask equipped with a stirrer, a dropping funnel, a thermometer, a reflux condenser, and a nitrogen inlet tube. 327g (7.11mol) was added under nitrogen atmosphere.
While heating and stirring at 80°C, 400 g (1.34 mol) of hexadecyl glycidyl ether was added dropwise over 3 hours. After completion of the dropwise addition, the mixture was further heated and stirred for 30 minutes under the same conditions, and then a distillation apparatus was attached, and ethanol and unreacted ethanolamine were distilled off under reduced pressure (79-81°C/20 Torr). 80℃/20Torr
While heating and stirring, 362.3 g (1.34 mol) of methyl hexadecanoate was added dropwise to this over 3 hours.
After the addition was completed, the mixture was further heated and stirred for 1 hour under the same conditions to obtain 801 g of a pale yellow crude product. By recrystallizing this once from hexane and twice from ethanol, the target compound (
a) 649 g (yield 81%) was obtained. Example 1 Preparation of a mixture of components (A) and (B): 60% by weight of compound (a) and 40% by weight of cholesterol [formula ()] are weighed into a glass screw cap sample bottle. Heat the sample bottle to 150℃ using a heating block, etc. When (a) and cholesterol are completely dissolved by heating, the heating is terminated and the mixture is left to cool in the air to obtain a paste-like mixture. Example 2 The mixture obtained in Example 1 was added to petrolatum (a).
A skin external preparation prepared by adding and blending the above mixture to Vaseline so that the amount of (a) is 15% by weight and the cholesterol is 10% by weight (product 1 of the present invention). In addition to this, a skin external preparation prepared by adding 4% by weight of glyceryl ether [in which R 10 is of the formula ()] (invention product 2), and vaseline (control)
The skin conductance and skin roughness were evaluated using the following method. The results are shown in Table 1. (Test method) Ten women between the ages of 20 and 50 who suffer from rough skin on their cheeks during the winter were used as subjects, and different samples were applied to the left and right cheeks once a day for two weeks. The next day after the two-week application was completed, the following tests were conducted. (1) Skin conductance After washing the face with warm water at 37℃ and resting for 20 minutes in a room with a temperature of 20℃ and humidity of 40%, the water content of the stratum corneum was measured using a skin conductance meter (manufactured by IBS). . As for the conductance value, the smaller the value, the rougher the skin, and if it is less than 5, the skin is severely rough.
On the other hand, if this value is 20 or higher, skin roughness is hardly observed. (2) Skin roughness score Skin roughness was observed with the naked eye and judged according to the following criteria. Scores were expressed as mean value ± standard deviation.
【表】 (結果)【table】 (result)
【表】
実施例 3
化合物(a)と、式()で示されるコレス
テロールと、ステアリン酸〔式()で、R6=
C17H33のもの〕を第2表に示すように配合した
水中油型乳化化粧料を製造し、実施例2と同様な
方法を用いて、皮膚コンダクタンス及び肌あれに
ついて評価した。結果を第3表に示す。[Table] Example 3 Compound (a), cholesterol represented by formula (), and stearic acid [in formula (), R 6 =
C 17 H 33 ] was formulated as shown in Table 2 to produce an oil-in-water emulsion cosmetic, and using the same method as in Example 2, skin conductance and skin roughness were evaluated. The results are shown in Table 3.
【表】【table】
【表】
実施例 4
化粧料(乳液)
<組成>
油相成分:
マカデミアンナツツ油 2.0(重量%)
スクワラン 5.0
ステアリン酸 1.0
化合物(a) 1.0
大豆リン脂質 0.5
グルコセレブロシド(牛脳抽出物)
0.5
モノステアリン酸ソルビタン 0.5
POE(60)硬化ヒマシ油 1.0
水相成分:
グリセリン 1.0
プロピレングリコール 1.0
メチルパラベン 0.3
香 料 0.1
精製水 全体を100とする量
<製造法>
油相成分を混合し、加熱溶解して70℃に保つ。
水相成分も同様に70℃で加熱混合し、この水相成
分に前述の油相部を加えて乳化機にて乳化する。
乳化物を熱交換機にて終温30℃まで冷却したのを
容器に充填して乳液を調製した。[Table] Example 4 Cosmetic (emulsion) <Composition> Oil phase components: Macadamia nut oil 2.0 (wt%) Squalane 5.0 Stearic acid 1.0 Compound (a) 1.0 Soybean phospholipid 0.5 Glucocerebroside (cow brain extract)
0.5 Sorbitan monostearate 0.5 POE (60) hydrogenated castor oil 1.0 Water phase components: Glycerin 1.0 Propylene glycol 1.0 Methylparaben 0.3 Fragrance 0.1 Purified water Amount to make the total 100 <Manufacturing method> Mix the oil phase components and heat and dissolve. and keep at 70℃.
The aqueous phase components are similarly heated and mixed at 70°C, and the above-mentioned oil phase is added to the aqueous phase components and emulsified using an emulsifier.
The emulsion was cooled to a final temperature of 30°C using a heat exchanger and then filled into a container to prepare an emulsion.
Claims (1)
分岐鎖の飽和若しくは不飽和の炭化水素基、
R4は炭素数9〜25の直鎖若しくは分岐鎖の飽
和若しくは不飽和の炭化水素基を示す) で表わされるアミド誘導体の一種又は二種以
上、 (B) コレステロール、コレステロール脂肪酸エス
テル、脂肪酸、トリグリセリド、セレブロシド
又はリン脂質の一種又は二種以上、 を含有することを特徴とする皮膚外用剤。 2 (A)成分と(B)成分の配合比が、重量比で8:2
〜2:8である特許請求の範囲第1項記載の皮膚
外用剤。 3 更に界面活性剤を含有する特許請求の範囲第
1項記載の皮膚外用剤。[Claims] 1st order components (A) and (B), (A) General formula () (In the formula, R 3 is a linear or branched saturated or unsaturated hydrocarbon group having 10 to 26 carbon atoms,
( R4 represents a linear or branched saturated or unsaturated hydrocarbon group having 9 to 25 carbon atoms); (B) cholesterol, cholesterol fatty acid ester, fatty acid, triglyceride; , one or more types of cerebrosides or phospholipids. 2 The blending ratio of component (A) and component (B) is 8:2 by weight.
The skin external preparation according to claim 1, wherein the ratio is 2:8. 3. The external preparation for skin according to claim 1, further comprising a surfactant.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2439187A JPS63192703A (en) | 1987-02-04 | 1987-02-04 | External agent for skin |
ES8800292A ES2013792A6 (en) | 1987-02-04 | 1988-02-02 | External agent for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2439187A JPS63192703A (en) | 1987-02-04 | 1987-02-04 | External agent for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63192703A JPS63192703A (en) | 1988-08-10 |
JPH0459285B2 true JPH0459285B2 (en) | 1992-09-21 |
Family
ID=12136865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2439187A Granted JPS63192703A (en) | 1987-02-04 | 1987-02-04 | External agent for skin |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS63192703A (en) |
ES (1) | ES2013792A6 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3871974T2 (en) * | 1987-02-12 | 1993-01-14 | Estee Lauder Inc | HAIR PROTECTIVE AGENT AND METHOD. |
US5087418A (en) * | 1987-02-25 | 1992-02-11 | Adir Jacob | Process for dry sterilization of medical devices and materials |
JPH0366604A (en) * | 1989-08-04 | 1991-03-22 | Kanebo Ltd | Dermal cosmetic |
JPH0647528B2 (en) * | 1990-03-07 | 1994-06-22 | キユーピー株式会社 | Cosmetics |
US5565207A (en) * | 1990-09-19 | 1996-10-15 | Pola Kasei Kogyo Kabushiki Kaisha | Scalp moisturizer and external skin preparation |
JP2931708B2 (en) * | 1991-07-18 | 1999-08-09 | ポーラ化成工業株式会社 | Hair restoration |
AU639373B2 (en) * | 1990-10-22 | 1993-07-22 | Unilever Plc | Cosmetic composition |
GB9100816D0 (en) * | 1991-01-15 | 1991-02-27 | Unilever Plc | Cosmetic composition |
FR2675045A1 (en) * | 1991-04-10 | 1992-10-16 | Carita Sa | Cosmetic composition having an antidehydrating effect which is usable in lipsticks |
CA2087691A1 (en) * | 1992-01-23 | 1993-07-24 | Peter Critchley | Cosmetic compositon |
US5372814A (en) * | 1992-02-05 | 1994-12-13 | Kao Corporation | Sterol derivative, process for producing the same and dermatologic external preparation |
FR2690343B1 (en) * | 1992-04-28 | 1995-09-01 | Inocosm Laboratoires | ANTI-RADICAL AND ANTI-LIPOPEROXIDANT COMPOSITION. |
WO1994000127A1 (en) * | 1992-06-19 | 1994-01-06 | The Regents Of The University Of California | Lipids for epidermal moisturization and repair of barrier function |
GB9308103D0 (en) * | 1993-04-20 | 1993-06-02 | Unilever Plc | Cosmetic composition |
US5368857A (en) * | 1993-11-15 | 1994-11-29 | Elizabeth Arden Company, Division Of Conopco, Inc. | Ceramide cosmetic compositions |
WO1995029151A1 (en) * | 1994-04-27 | 1995-11-02 | Gist-Brocades B.V. | Short chain 2-hydroxycarboxylic acid-based derivatives of ceramides |
GB9421185D0 (en) * | 1994-10-20 | 1994-12-07 | Unilever Plc | Personal car composition |
JPH09508925A (en) * | 1994-11-28 | 1997-09-09 | ギスト ブロカデス ベスローテン フェンノートシャップ | Topical application of ceramides |
FR2730410B1 (en) * | 1995-02-15 | 1997-03-21 | Oreal | COSMETIC COMPOSITION COMPRISING A COMBINATION OF CERAMIDES AND ITS USE |
TW453881B (en) * | 1995-10-16 | 2001-09-11 | Kao Corp | Cosmetic composition comprising amide derivatives |
EP0866693B1 (en) * | 1995-10-18 | 2003-08-20 | Mary Kay Inc. | Topically applied, structural cellulite treatments |
US5571518A (en) | 1995-10-30 | 1996-11-05 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions containing tricholine citrate |
US5667770A (en) * | 1996-03-25 | 1997-09-16 | Elizabeth Arden Company, Division Of Conopco, Inc. | Long wearing lipstick |
KR19980034991A (en) | 1996-11-11 | 1998-08-05 | 안용찬 | Non-natural ceramide-related compounds and external skin preparations containing them |
CO5111023A1 (en) | 1998-12-31 | 2001-12-26 | Kimberly Clark Co | COMPOSITION OF ABSORBENT ARTICLE AND METHOD FOR USE TO SEQUEST SKIN IRRITANTS |
KR100371491B1 (en) * | 1999-07-27 | 2003-02-07 | 주식회사 두산 | Cream Composition For Skin Care |
JP4780817B2 (en) * | 2000-02-07 | 2011-09-28 | 株式会社ノエビア | Epidermis ceramide production promoter and epidermis moisturizing function improving agent containing the same |
JP4350269B2 (en) | 2000-05-11 | 2009-10-21 | 高砂香料工業株式会社 | Cosmetic additive composition |
WO2003049709A1 (en) | 2001-12-10 | 2003-06-19 | Kao Corporation | Ceramide emulsions |
TW200413020A (en) * | 2002-07-05 | 2004-08-01 | Kose Corp | Vesicle dispersion and cosmetic containing the same |
AU2003277638A1 (en) * | 2002-11-15 | 2004-06-15 | Kose Corporation | Semitransparent cosmetics |
JP2006273747A (en) * | 2005-03-29 | 2006-10-12 | Kose Corp | O/w/o type emulsion cosmetic |
JP2007001950A (en) * | 2005-06-27 | 2007-01-11 | Pola Chem Ind Inc | Ceramide-containing skin external preparation |
CN101677926B (en) * | 2007-03-01 | 2012-06-06 | 高砂香料工业株式会社 | Lipid composition having excellent shape retention property and product |
JP4825981B2 (en) * | 2007-03-27 | 2011-11-30 | 大学共同利用機関法人自然科学研究機構 | Waveguide junction |
JP5432470B2 (en) * | 2007-05-01 | 2014-03-05 | 株式会社ファンケル | Ceramide solution and external preparation for skin |
JP6040079B2 (en) * | 2013-03-28 | 2016-12-07 | 花王株式会社 | Method for producing amide derivative |
JP6564223B2 (en) * | 2015-03-31 | 2019-08-21 | 小林製薬株式会社 | Composition for external use |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61271205A (en) * | 1985-05-24 | 1986-12-01 | Kanebo Ltd | Skin cosmetic |
JPS61289013A (en) * | 1985-06-18 | 1986-12-19 | Pola Chem Ind Inc | Skin external agent |
JPS63141908A (en) * | 1986-12-03 | 1988-06-14 | Kanebo Ltd | Emulsion-type cosmetic |
-
1987
- 1987-02-04 JP JP2439187A patent/JPS63192703A/en active Granted
-
1988
- 1988-02-02 ES ES8800292A patent/ES2013792A6/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61271205A (en) * | 1985-05-24 | 1986-12-01 | Kanebo Ltd | Skin cosmetic |
JPS61289013A (en) * | 1985-06-18 | 1986-12-19 | Pola Chem Ind Inc | Skin external agent |
JPS63141908A (en) * | 1986-12-03 | 1988-06-14 | Kanebo Ltd | Emulsion-type cosmetic |
Also Published As
Publication number | Publication date |
---|---|
JPS63192703A (en) | 1988-08-10 |
ES2013792A6 (en) | 1990-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0459285B2 (en) | ||
EP0534286A1 (en) | External skin care preparation | |
WO2000061097A1 (en) | External preparation compositions | |
JPH048104B2 (en) | ||
JPS6027646B2 (en) | cosmetics | |
JPH04112810A (en) | Aqueous cosmetic and production thereof | |
JPH024335B2 (en) | ||
JPS63192704A (en) | Cosmetic | |
JPH0142934B2 (en) | ||
CN106413681A (en) | Ceramide-formulated external agent composition | |
JPS61204109A (en) | Emulsion-type composition for external use | |
JPS60184005A (en) | Cosmetic for preventing aging of skin | |
JP7126753B2 (en) | Skin topical agent | |
JP4112741B2 (en) | Moisturizer | |
JPH0669532B2 (en) | Oil-in-water emulsion composition | |
JPH0316172B2 (en) | ||
JPH05213731A (en) | Skin external agent | |
JP3522794B2 (en) | External preparation for skin | |
JPH06157276A (en) | Skin external preparation | |
JP7126754B2 (en) | Skin topical agent | |
JPS63227513A (en) | Dermatic drug for external application | |
JPS62132808A (en) | Hair-forming, hair-growing agent | |
JPH0565485B2 (en) | ||
JPH07106974B2 (en) | Topical skin | |
JP3462332B2 (en) | Oil gelling agent and cosmetic containing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |